Information for healthcare professionals: risk of transmission of blood-borne pathogens from shared use of insulin pens.

Press Release/Announcement

Information for healthcare professionals: risk of transmission of blood-borne pathogens from shared use of insulin pens.

March 4, 2015

FDA Alert. Silver Spring, MD; US Food and Drug Administration: March 19, 2009.

This announcement alerts clinicians and patients that insulin pens and insulin cartridges are never to be used on more than one patient.

Free full text

Related Resources From the Same Author(s)

FDA alerts patients and health care professionals of EpiPen auto-injector errors related to device malfunctions and user administration.

April 8, 2020

FDA 101: How to Use the Consumer Complaint System and MedWatch.

April 23, 2012

Medication errors resulting from confusion between risperidone (Risperdal) and ropinirole (Requip).

June 22, 2011

Important information for the safe use of Tussionex Pennkinetic Extended-Release Suspension.

August 11, 2010

Wear face masks with no metal during MRI exams.

December 16, 2020

Tamiflu (oseltamivir) for oral suspension: potential medication errors.

November 3, 2009

Relenza (zanamivir) inhalation powder.

March 12, 2010

Potentially fatal errors with GDH-PQQ [glucose dehydrogenase pyrroloquinoline quinone] glucose monitoring technology.

March 12, 2010

Five Medication Safety Tips for Older Adults.

February 15, 2024

FDA requires label warnings to prohibit sharing of multi-dose diabetes pen devices among patients.

March 11, 2015

Related Resources

Letter to Health Care Providers: Safe Use of Surgical Staplers and Staples.

October 7, 2021

FDA Safety Communication: update--robotically-assisted surgical devices in mastectomy.

August 20, 2021

FDA advises health care professionals and patients about insulin pen packaging and dispensing.

October 28, 2020

FDA identifies harm reported from sudden discontinuation of opioid pain medicines and requires label changes to guide prescribers on gradual, individualized tapering.

April 17, 2019

FDA Safety Communication: use caution with implanted pumps for intrathecal administration of medicines for pain management.

November 28, 2018

Severe hyperglycemia in patients incorrectly using insulin pens at home.

October 25, 2017

FDA requires label warnings to prohibit sharing of multi-dose diabetes pen devices among patients.

March 11, 2015

Serious medication errors from intravenous administration of nimodipine oral capsules.

August 11, 2010

Potentially fatal errors with GDH-PQQ [glucose dehydrogenase pyrroloquinoline quinone] glucose monitoring technology.

March 12, 2010

Maalox Total Relief and Maalox Liquid Products: Medication Use Errors.

March 3, 2010

See More About The Topic

Health Care Providers

Patients

Endocrinology

Insulin

Nosocomial Infections

Information for healthcare professionals: risk of transmission of blood-borne pathogens from shared use of insulin pens.

Connect With Us

Sign up for Email Updates

Agency for Healthcare Research and Quality

Information for healthcare professionals: risk of transmission of blood-borne pathogens from shared use of insulin pens.

Connect With Us

Sign up for Email Updates

Agency for Healthcare Research and Quality

Submit Your Innovations

Continue as a Guest

Continue Logged In

Submit Your Innovations

Continue as a Guest

Continue logged in

New Users to the PSNet site

Submit Your Training

Continue as a Guest

Continue Logged In

Submit Your Training

Continue as a Guest

Continue Logged In

New Users to the PSNet site

Submit Your Toolkit

Continue as a Guest

Continue Logged In

Submit Your Toolkit

Continue as a Guest

Continue Logged In

New Users to the PSNet site

Submit Your WebM&M Case

Continue as a Guest

Continue Logged In

Submit Your WebM&M Case

Continue as a Guest

Already have a PSNet

Account?

New Users